Granger, C.B.

patient stroke infarction trial nonhemorrhagic stroke study event nonhemorrhagic mortality therapy investigator baseline ck-mb group table elevation heart predictor treatment hemorrhage analysis heparin death result outcome thrombolytic thrombolysi diabetes thrombolytic therapy model effect in-hospital 30- day mortality pursuit intervention ratio syndrome circulation atrial fibrillation /flutter 30 days eptifibatide angina randomized intracranial factor cardiol gusto-i site investigators intracranial hemorrhage coll cardiol angioplasty st-segment elevation difference end-point enzyme hospital heart rate characteristic history incidence artery level atrial st-segment fibrillation percutaneou 30- /iiia glycoprotein pursuit trial peak ck-mb ratios heparin discontinuation surgery ischemic attack arrhythmia 6- month mortality platelet risk factors follow-up enrolment